Literature DB >> 10901364

Osteopontin is required for full expression of the transformed phenotype by the ras oncogene.

Y Wu1, D T Denhardt, S R Rittling.   

Abstract

The secreted phosphoprotein osteopontin (OPN) is strongly associated with the process of neoplastic transformation, based both on its pattern of expression in vivo and in vitro and on functional analyses. We have used 3T3 cells derived from wildtype and OPN-deficient mice and transformed by transfection with oncogenic ras to assess the role of OPN in transformation in vitro and in tumorigenesis in vivo. There was no effect of an absence of OPN on the ability of the cells to undergo immortalization or to form morphologically transformed foci following ras transfection. Wildtype and OPN-deficient cell lines were established from such foci, and lines with similar ras mRNA levels selected for further analysis. Ras-transformed cell lines from both wildtype and OPN-deficient mice could form colonies in soft agar indicating that this process can occur in the absence of OPN. However, the ability of the OPN-deficient cell lines to form colonies was reduced as compared to wildtype cell lines. Tumorigenesis in syngeneic and nude mice was assessed for a subset of cell lines that formed colonies efficiently in soft agar. Cell lines unable to make OPN formed tumors in these mice much more slowly than wildtype cells, despite similar growth of the cells on plastic and in soft agar. Taken together, these results indicate that maximal transformation by ras requires OPN expression, and implicate increased OPN expression as an important effector of the transforming activity of the ras oncogene.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10901364      PMCID: PMC2363489          DOI: 10.1054/bjoc.2000.1200

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  60 in total

1.  Cellular tumorigenicity in nude mice: correlation with cell growth in semi-solid medium.

Authors:  V H Freedman; S I Shin
Journal:  Cell       Date:  1974-12       Impact factor: 41.582

2.  Altered wound healing in mice lacking a functional osteopontin gene (spp1).

Authors:  L Liaw; D E Birk; C B Ballas; J S Whitsitt; J M Davidson; B L Hogan
Journal:  J Clin Invest       Date:  1998-04-01       Impact factor: 14.808

3.  Distinct roles of osteopontin in host defense activity and tumor survival during squamous cell carcinoma progression in vivo.

Authors:  H C Crawford; L M Matrisian; L Liaw
Journal:  Cancer Res       Date:  1998-11-15       Impact factor: 12.701

4.  Identification of osteopontin as a novel ligand for the integrin alpha8 beta1 and potential roles for this integrin-ligand interaction in kidney morphogenesis.

Authors:  S Denda; L F Reichardt; U Müller
Journal:  Mol Biol Cell       Date:  1998-06       Impact factor: 4.138

5.  Increased expression of osteonectin and osteopontin, two bone matrix proteins, in human breast cancer.

Authors:  A Bellahcène; V Castronovo
Journal:  Am J Pathol       Date:  1995-01       Impact factor: 4.307

6.  Osteopontin expression in a group of lymph node negative breast cancer patients.

Authors:  A B Tuck; F P O'Malley; H Singhal; J F Harris; K S Tonkin; N Kerkvliet; Z Saad; G S Doig; A F Chambers
Journal:  Int J Cancer       Date:  1998-10-23       Impact factor: 7.396

7.  Detection of mouse osteopontin by western blotting.

Authors:  S R Rittling; F Feng
Journal:  Biochem Biophys Res Commun       Date:  1998-09-18       Impact factor: 3.575

Review 8.  Recent insights into the role of integrins in cancer metastasis.

Authors:  P Clezardin
Journal:  Cell Mol Life Sci       Date:  1998-06       Impact factor: 9.261

9.  Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro.

Authors:  S R Rittling; H N Matsumoto; M D McKee; A Nanci; X R An; K E Novick; A J Kowalski; M Noda; D T Denhardt
Journal:  J Bone Miner Res       Date:  1998-07       Impact factor: 6.741

10.  NF-kappaB mediates alphavbeta3 integrin-induced endothelial cell survival.

Authors:  M Scatena; M Almeida; M L Chaisson; N Fausto; R F Nicosia; C M Giachelli
Journal:  J Cell Biol       Date:  1998-05-18       Impact factor: 10.539

View more
  22 in total

1.  Short form of α9 promotes α9β1 integrin-dependent cell adhesion by modulating the function of the full-length α9 subunit.

Authors:  Shigeyuki Kon; Amha Atakilit; Dean Sheppard
Journal:  Exp Cell Res       Date:  2011-04-16       Impact factor: 3.905

2.  Inhibition of osteopontin reduces liver metastasis of human pancreatic cancer xenografts injected into the spleen in a mouse model.

Authors:  Keisuke Ohno; Hidefumi Nishimori; Takahiro Yasoshima; Kenjiro Kamiguchi; Fumitake Hata; Rika Fukui; Koichi Okuya; Yasutoshi Kimura; Ryuichi Denno; Shigeyuki Kon; Toshimitsu Uede; Noriyuki Sato; Koichi Hirata
Journal:  Surg Today       Date:  2010-03-26       Impact factor: 2.549

3.  Override of the osteoclast defect in osteopontin-deficient mice by metastatic tumor growth in the bone.

Authors:  Tajneen Natasha; Misty Kuhn; Owen Kelly; Susan R Rittling
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

4.  Significance of plasma osteopontin levels in patients with bladder urothelial carcinomas.

Authors:  Li Zhao; Yalin Wang; Nan Qu; Chen Huang; Lijun Chen
Journal:  Mol Diagn Ther       Date:  2012-10       Impact factor: 4.074

5.  Osteopontin knockdown suppresses tumorigenicity of human metastatic breast carcinoma, MDA-MB-435.

Authors:  Lalita A Shevde; Rajeev S Samant; Jason C Paik; Brandon J Metge; Ann F Chambers; Graham Casey; Andra R Frost; Danny R Welch
Journal:  Clin Exp Metastasis       Date:  2006-07-09       Impact factor: 5.150

6.  Elevated plasma osteopontin associated with gastric cancer development, invasion and survival.

Authors:  Chun-Ying Wu; Ming-Shiang Wu; En-Pei Chiang; Cheng-Chung Wu; Yi-Ju Chen; Chien-Jen Chen; Nai-Hui Chi; Gran-Hum Chen; Jaw-Town Lin
Journal:  Gut       Date:  2006-12-05       Impact factor: 23.059

7.  The prognostic significance of preoperative plasma levels of osteopontin in patients with hepatocellular carcinoma.

Authors:  Hui Zhang; Qing-Hai Ye; Ning Ren; Lei Zhao; Yan-Fang Wang; Xin Wu; Hui-Chuan Sun; Lu Wang; Bo-Heng Zhang; Yin-Kun Liu; Zhao-You Tang; Lun-Xiu Qin
Journal:  J Cancer Res Clin Oncol       Date:  2006-06-20       Impact factor: 4.553

8.  Novel murine mammary epithelial cell lines that form osteolytic bone metastases: effect of strain background on tumor homing.

Authors:  Yanping Chen; Susan R Rittling
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

9.  Comprehensive genomic analysis contrasting primary colorectal cancer and matched liver metastases.

Authors:  Akio Shiomi; Masatoshi Kusuhara; Takashi Sugino; Teiichi Sugiura; Keiichi Ohshima; Takeshi Nagashima; Kenichi Urakami; Masakuni Serizawa; Hideyuki Saya; Ken Yamaguchi
Journal:  Oncol Lett       Date:  2021-04-12       Impact factor: 2.967

10.  Osteopontin expression in intratumoral astrocytes marks tumor progression in gliomas induced by prenatal exposure to N-ethyl-N-nitrosourea.

Authors:  Taichang Jang; Todd Savarese; Hoi Pang Low; Sunchin Kim; Hannes Vogel; David Lapointe; Timothy Duong; N Scott Litofsky; James M Weimann; Alonzo H Ross; Lawrence Recht
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.